CPE End-of-Year Video 2024 – Year in Review
Cancer Patients Europe’s 2024 year-in-review video: achievements in policy advocacy, patient surveys, EU engagement, and cancer care improvement across Europe. Read More
Home »
2024
CPE Webinar Series: Smoking Cessation – A Step Towards a Cancer-Free Environment – EWAC 2024
CPE’s EWAC 2024 webinar on smoking cessation inequalities: tobacco control policies, cessation support access, and WHO guideline adoption recommendations. Read More
CPE Webinar Series: Survivorship – EWAC 2024
CPE’s EWAC 2024 webinar on survivorship inequalities: post-treatment care, Right to Be Forgotten, mental health support, and EU policy recommendations. Read More
CPE Webinar Series: Innovation in Treatment – EWAC 2024
CPE’s EWAC 2024 webinar on treatment innovation inequalities: targeted therapies, immunotherapy access, and EU policy recommendations. Read More
CPE Webinar Series: Innovative Diagnostics and Accurate Diagnosis – EWAC 2024
CPE’s EWAC 2024 webinar on diagnostic inequalities in Europe: genomic testing, liquid biopsy access, and policy recommendations for EU institutions. Read More
CPE Webinar Series: Prevention & Early Diagnosis – EWAC 2024
CPE’s EWAC 2024 webinar on prevention and early diagnosis inequalities across Europe with policy recommendations for EU institutions. Read More
Cancer Patients Europe Annual Activity Report 2023
CPE’s 2023 Annual Report: First General Assembly, 38 members across 19 countries, myC genomic testing campaign, HTA Task Force, and Patient Leadership event. Read More
QUALITOP: Final Conference on Results and Patient Perspective – Event Report
QUALITOP consortium’s final conference report documents 4 years of EU research on quality of life in cancer immunotherapy, including Smart Digital Platform development. Read More
Call to Action of Concerned Stakeholders on the Implementation of the EU HTA and Joint Clinical Assessment for ATMPs (Updated August 2024)
39 stakeholders call on EU HTA Coordination Group to adopt fit-for-purpose JCA methodology for ATMPs, recognising single-arm trials and real-world evidence. Read More
CPE Patient Survey on Metastatic Breast Cancer Biomarkers (ESR1 and Liquid Biopsy)
CPE’s survey on ESR1 mutations and liquid biopsy awareness among metastatic breast cancer patients across 5 EU countries informed the 2025 White Paper. Read More